Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

U.S. Chemicals Industry Analysis

UpdatedJan 22, 2026
DataAggregated Company Financials
Companies131
  • 7D0.6%
  • 3M3.7%
  • 1Y-4.0%
  • YTD7.2%

The Chemicals industry has stayed flat over the last week. Unfortunately though, the industry is down 4.0% over the past 12 months. Earnings are forecast to grow by 23% annually.

Industry Valuation and Performance

Has the U.S. Chemicals Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 22 Jan 2026US$763.4bUS$372.0bUS$11.0b23.6x69.3x2.1x
Sat, 20 Dec 2025US$718.3bUS$371.7bUS$11.0b23.9x65.4x1.9x
Mon, 17 Nov 2025US$712.3bUS$371.6bUS$11.0b22.9x64.8x1.9x
Wed, 15 Oct 2025US$741.6bUS$367.8bUS$15.6b25x47.7x2x
Fri, 12 Sep 2025US$781.1bUS$367.7bUS$15.5b26x50.4x2.1x
Sun, 10 Aug 2025US$766.5bUS$367.9bUS$15.7b24.8x48.9x2.1x
Tue, 08 Jul 2025US$805.6bUS$376.6bUS$17.9b23.1x44.9x2.1x
Thu, 05 Jun 2025US$776.8bUS$378.4bUS$18.0b23.1x43.1x2.1x
Sat, 03 May 2025US$753.1bUS$379.0bUS$19.2b19.5x39.3x2x
Mon, 31 Mar 2025US$773.7bUS$380.9bUS$23.0b19.4x33.6x2x
Wed, 26 Feb 2025US$810.9bUS$380.9bUS$23.4b21.9x34.6x2.1x
Fri, 24 Jan 2025US$822.2bUS$384.4bUS$23.4b22.8x35.1x2.1x
Sun, 22 Dec 2024US$790.2bUS$384.3bUS$23.4b20.4x33.7x2.1x
Tue, 19 Nov 2024US$841.3bUS$385.1bUS$23.8b23.3x35.3x2.2x
Thu, 17 Oct 2024US$904.0bUS$388.7bUS$24.2b26.7x37.4x2.3x
Sat, 14 Sep 2024US$853.7bUS$383.8bUS$23.4b25.6x36.4x2.2x
Mon, 12 Aug 2024US$824.4bUS$384.5bUS$23.8b24.6x34.6x2.1x
Wed, 10 Jul 2024US$802.0bUS$379.9bUS$23.4b25.2x34.2x2.1x
Fri, 07 Jun 2024US$822.1bUS$377.3bUS$23.4b27.2x35.1x2.2x
Sun, 05 May 2024US$809.7bUS$378.3bUS$23.8b22.2x34.1x2.1x
Tue, 02 Apr 2024US$854.5bUS$384.6bUS$25.6b21.4x33.4x2.2x
Thu, 29 Feb 2024US$809.7bUS$384.6bUS$25.4b19.6x31.8x2.1x
Sat, 27 Jan 2024US$785.7bUS$398.6bUS$31.6b20.5x24.9x2x
Mon, 25 Dec 2023US$811.0bUS$398.4bUS$31.6b21.7x25.7x2x
Wed, 22 Nov 2023US$763.5bUS$398.8bUS$31.6b19.1x24.1x1.9x
Fri, 20 Oct 2023US$726.8bUS$412.0bUS$31.3b15.2x23.2x1.8x
Sun, 17 Sep 2023US$779.3bUS$412.0bUS$31.2b16.9x25x1.9x
Tue, 15 Aug 2023US$789.7bUS$412.0bUS$31.2b15.5x25.3x1.9x
Thu, 13 Jul 2023US$820.8bUS$444.3bUS$39.1b13.9x21x1.8x
Sat, 10 Jun 2023US$780.0bUS$444.6bUS$39.1b13x20x1.8x
Mon, 08 May 2023US$785.6bUS$443.7bUS$39.6b13x19.8x1.8x
Wed, 05 Apr 2023US$795.3bUS$452.0bUS$42.6b12.7x18.7x1.8x
Fri, 03 Mar 2023US$829.3bUS$450.6bUS$40.0b13.3x20.7x1.8x
Sun, 29 Jan 2023US$828.4bUS$458.3bUS$41.8b15.4x19.8x1.8x
Price to Earnings Ratio

19.8x


Total Market Cap: US$828.4bTotal Earnings: US$41.8bTotal Revenue: US$458.3bTotal Market Cap vs Earnings and Revenue0%0%0%
U.S. Chemicals Industry Price to Earnings3Y Average 39.1x202420252026
Current Industry PE
  • Investors are optimistic on the American Chemicals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 69.3x which is higher than its 3-year average PE of 39.1x.
  • The 3-year average PS ratio of 2.4x is higher than the industry's current PS ratio of 2.1x.
Past Earnings Growth
  • The earnings for companies in the Chemicals industry have declined 36% per year over the last three years,
  • Revenues have also declined 6.7% per year.
  • This means overall sales from these companies are declining and profits are subsequently falling as well.

Industry Trends

Which industries have driven the changes within the U.S. Materials industry?

US Market-0.93%
Materials1.39%
Chemicals0.60%
Fertilizers and Agricultural Chemicals2.54%
Diversified Chemicals1.90%
Specialty Chemicals1.17%
Industrial Gases-0.46%
Commodity Chemicals-0.62%
Industry PE
  • Investors are most optimistic about the Specialty Chemicals industry which is trading above its 3-year average PE ratio of 60.4x.
    • Analysts are expecting annual earnings growth of 24.8%, which is higher than its past year's earnings decline of 2.1% per year.
Forecasted Growth
  • Analysts are most optimistic on the Diversified Chemicals industry, expecting annual earnings growth of 88% over the next 5 years.
  • In contrast, the Fertilizers and Agricultural Chemicals industry is expected to see its earnings grow by 7.9% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ECL EcolabUS$279.861.5%
+US$1.2b		15.8%PE39.9x
CF CF Industries HoldingsUS$91.868.0%
+US$1.1b		-1.8%PE10.4x
CTVA CortevaUS$71.482.2%
+US$1.0b		14.3%PE28.7x
SOLS Solstice Advanced MaterialsUS$63.4310.6%
+US$961.9m		n/aPE30.6x
PPG PPG IndustriesUS$112.543.7%
+US$890.9m		-8.4%PE19.9x

Latest News

SOLS
US$63.43
Solstice Advanced Materials
7D
10.6%
1Y
n/a

There's Reason For Concern Over Solstice Advanced Materials, Inc.'s (NASDAQ:SOLS) Massive 27% Price Jump

Jan 22
There's Reason For Concern Over Solstice Advanced Materials, Inc.'s (NASDAQ:SOLS) Massive 27% Price Jump
LIN
US$439.35
Linde
7D
-0.1%
1Y
-0.7%
CF
US$91.86
CF Industries Holdings
7D
8.0%
1Y
-1.8%
EMN
US$68.30
Eastman Chemical
7D
-1.4%
1Y
-25.9%

EMN: Cost Savings And Free Cash Flow Will Support Earnings Recovery Potential

Narrative Update Analysts have trimmed their consolidated price expectations for Eastman Chemical by around $1. They are factoring in softer revenue growth assumptions, slightly lower future P/E multiples, and a mixed set of recent target changes that balance cautious industry views with confidence in cash generation and margin resilience.
SQM
US$81.81
Sociedad Química y Minera de Chile
7D
-1.6%
1Y
112.6%

SQM: Higher Lithium Hopes Will Face Persistent Chilean Royalty Pressure

Analysts have lifted their fair value estimate for Sociedad Química y Minera de Chile to US$40 from US$37, reflecting updated assumptions for higher revenue growth, stronger profit margins, a lower discount rate, and a reduced future P/E multiple, supported by recent price target increases and more constructive sector views in Street research. Analyst Commentary Recent Street research on Sociedad Química y Minera de Chile highlights a mixed backdrop, with several firms lifting price targets and turning more constructive on lithium and broader sector sentiment.
BCPC
US$168.95
Balchem
7D
5.6%
1Y
4.2%

BCPC: Share Repurchases And Rising Dividend Will Support Attractive Future Returns

Analysts have maintained their Balchem fair value estimate at US$191, with only small tweaks to the discount rate, revenue growth, profit margin, and forward P/E assumptions. This reflects a largely unchanged view on the stock's risk and earnings profile.
ALB
US$180.06
Albemarle
7D
1.4%
1Y
99.5%

ALB: Future Returns Will Hinge On Sustained Lithium Pricing Strength

The analyst price target for Albemarle has been raised from about $125.49 to roughly $147.79 as analysts factor in higher lithium price assumptions, improved profit margin expectations, and a lower future P/E multiple, supported by a broad wave of recent upgrades and target increases across major research firms. Analyst Commentary Recent research on Albemarle reflects a clear shift toward more constructive views, with several upgrades and higher targets built around revised lithium price decks, inventory tightness, and evolving demand themes such as energy storage and physical AI.
APD
US$263.11
Air Products and Chemicals
7D
-1.5%
1Y
-17.0%

APD: Backlog Execution And Decarbonization Projects Will Shape Turnaround Confidence

Our analyst price target for Air Products and Chemicals has been trimmed by about $2 to $291, reflecting a slightly lower fair value as analysts factor in recent target cuts from BofA, RBC, and JPMorgan, while acknowledging growing confidence in the turnaround plan and backlog execution. Analyst Commentary Recent Street research around Air Products and Chemicals points to a mix of optimism about execution and caution around project risk and valuation, with several firms adjusting their price targets while reiterating a wait and see stance on key projects and the turnaround plan.
PPG
US$112.54
PPG Industries
7D
3.7%
1Y
-8.4%
FUL
US$59.49
H.B. Fuller
7D
-8.1%
1Y
-3.7%

FUL: Higher P/E Expectations Will Shape Medium Term Earnings Power

Analysts have raised their price targets for H.B. Fuller, reflected in the fair value estimate increasing from $68.83 to $71.71. This change is based on a higher assumed future P/E multiple, along with slightly revised assumptions for the discount rate, revenue growth, and profit margins.
NEU
US$644.62
NewMarket
7D
-9.1%
1Y
30.9%
SHW
US$356.31
Sherwin-Williams
7D
0.6%
1Y
-0.4%

SHW: Pricing Power And Margins Will Be Tested In Mixed Chemicals Backdrop

Narrative Update We are making a small upward adjustment to our Sherwin-Williams price target of about $0.80, reflecting analysts' mixed but generally constructive updates to revenue growth, margins, and long term P/E assumptions following recent Street research. Analyst Commentary Recent Street research on Sherwin-Williams shows a mix of optimism and caution, with price targets clustered in a relatively tight range and ratings spread between Neutral and Buy.
ECL
US$279.86
Ecolab
7D
1.5%
1Y
15.8%

ECL: Fair Outlook Balances Margin Strength With Uncertain Chemical And Agriculture Backdrop

Analysts have inched their fair value estimate for Ecolab higher, with the price target moving by about US$2.56 to US$294.71, citing updated views on revenue growth potential, a slightly adjusted discount rate, and ongoing discussion of industry catalysts such as chemical sector oversupply, mixed agriculture trends, and possible demand support from improving PMI indicators and future rate cuts. Analyst Commentary Recent research updates around Ecolab point to a generally constructive stance, with price targets nudging higher and coverage being reinstated with a positive angle.
CTVA
US$71.48
Corteva
7D
2.2%
1Y
14.3%

CTVA: Planned Seed And Pesticide Split Will Support Future Earnings Power

Analysts lifted their blended fair value estimate for Corteva by about $0.19 to roughly $77.95 per share, reflecting updated price targets that factor in a mixed backdrop for chemicals and agriculture but continued confidence in the company’s ability to increase earnings. Analyst Commentary Recent research on Corteva reflects a mix of optimism and caution, with price targets clustered in the mid to high US$70s and one outlier in the low US$80s.
WLK
US$86.68
Westlake
7D
-3.5%
1Y
-26.4%

WLK: Capacity Closures And Impairment Charges Will Shape Fairly Balanced Prospects

Analysts have nudged their price target for Westlake slightly higher to about US$82 per share, reflecting updated assumptions around discount rates, revenue growth, profit margins, and future P/E expectations. What's in the News Westlake plans to shut certain North American chlorovinyl facilities, including a PVC plant in Aberdeen, Mississippi, a VCM plant and a diaphragm chlor alkali unit in Lake Charles, Louisiana, and its styrene plant in Lake Charles, with cessation of operations targeted for December 2025 and an expected workforce reduction of about 295 employees (company announcement).
ICL
US$5.38
ICL Group
7D
-2.4%
1Y
-11.2%